close
MENU
1 mins to read

Rear View: the best of NBR



Susan Wood looks at the best of NBR this week including continuing analysis of Xero's NZX delisting and the companies continuing to experience global growth.

Susan Wood
Fri, 17 Nov 2017

Susan Wood looks at the best of NBR this week including continuing analysis of Xero's NZX delisting and the companies new and old continuing to experience global growth (subscribe at nbr.co.nz/subscribe or claim a 30-day trial via nbr.co.nz/free).

Aussie analyst jacks up Xero target price, NZ broker finds ‘blemish’ – Chris Keall

NZX left no stone unturned to keep Xero – Tim Hunter

Peters’ lawyer accuses journalists of ‘charading’ as pension case proceeds – Victoria Young 

Why FishFish has floundered while BurgerBurger beefs up – Fiona Rotherham

Live from the Hive – Susan Wood

Douglas Pharma aims to double revenue by 2025 – Fiona Rotherham

Timely lands $7m investment - Chris Keall

Rakon returns to profit but doubts cast over sustainability – Calida Smylie

Pushpay boss accelerates US listing timetable – but says will stay on NZX, too – Chris Keall

Susan Wood
Fri, 17 Nov 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Rear View: the best of NBR
71713
false